Abstract:Background: Glioma is a common primary central nervous system tumor, and there is still a lack of effective therapeutic drugs that can effectively improve the survival rate of patients in clinical. Bufalin has a good effect in the treatment of various tumors, but the mechanism of how it promotes the apoptosis of glioma cells is still unclear. The aim of this study was to investigate the drug target of bufalin acting on glioma cells, and to clarify the mechanism of apoptosis. Methods: Cell viability and proliferation were evaluated by cck-8 and colony formation assay. Then, the cell cycle and apoptosis, intracellular ion homeostasis, oxidative stress levels and mitochondrial damage were detected after bufalin treatment. DARTS-PAGE technology combined with LC-MS/MS were employed to explore the drug targets of bufalin on U251 cells. Molecular docking and western blot were used to further identify the potential targets. siRNA of Annexin A2 and a DRP1 protein inhibitor Mdivi-1 were also used to verify the target of bufalin.Results: Bufalin upregulated the expression of cytochrome C, cleaved caspase 3, p-Chk1 and p-p53 proteins to cause U251 cell apoptosis and cycle arrest in S phase. Bufalin can also induce oxidative stress in U251 cells, destroy intracellular ion homeostasis, and cause mitochondrial damage. The expression of mitochondrial separation/fusion-related proteins in U251 cells was abnormal, Annexin A2 and DRP1 protein were translocated from cytoplasm to mitochondria, and MFN2 protein was released from mitochondria into cytoplasm after bufalin treatment, which disrupted the mitochondrial division/fusion balance of U251 cells. Conclusions: Our research indicated that bufalin can cause Annexin A2 and DRP1 oligomerization to be located on the surface of mitochondria, and disrupt the mitochondrial division/fusion balance to induce U251 cell apoptosis.

Microarray and Biochemical Analysis of Bufalin-Induced Apoptosis of HL-60 Cells

Bufalin Inhibits Htert Expression and Colorectal Cancer Cell Growth by Targeting CPSF4

Sinomenine Enhanced Aclarubicin-Induced Apoptosis by Blocking Nf-Kappa B Pathway in Hl-60 Cells

Study on Proteomics of HeLa Cell Apoptosis in Bufalin-Induced Human Cervical Carcinoma

WT1 Downregulation During K562 Cell Differentiation and Apoptosis Induced by Bufalin.

[Molecular Mechanism of HL-60 Cell Apoptosis Induced by Baicalin].

[Beta-Elemene Enhances Aclarubicin-Induced Apoptotic Effect in HL-60 Cells and Its Mechanism.].

Bufalin induces apoptosis of pancreatic cancer cells via the JNK signaling pathway

Effect of Bufotalin on the Apoptosis of BGC-823 Cells

Apoptosis of Human Pancreatic Cancer Cell Induced by Bufalin and Its Effects on Survivin Expression in Nude Mice

Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells

Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis

Bufalin induces apoptosis in the U‑2OS human osteosarcoma cell line via triggering the mitochondrial pathway.

Bufalin Induced Mitochondrial Dysfunction Promotes Apoptosis of Glioma Cells by Regulating Annexin A2 and DRP1 Proteins

Bufalin induced apoptosis in SCC-4 human tongue cancer cells by decreasing Bcl-2 and increasing Bax expression via the mitochondria-dependent pathway

Berbamine-Induced Apoptosis in Human Leukemia K562 Cells.

Bufalin induces mitochondrial dysfunction and promotes apoptosis of glioma cells by regulating Annexin A2 and DRP1 protein expression

Roles of Phosphorylated P210bcr/abl and Hsp90 Protein in Apoptosis Induced by Berbamine in K562 Cells.

Global Metabolomic and Lipidomic Analysis Reveal the Synergistic Effect of Bufalin in Combination with Cinobufagin Against HepG2 Cells.

Research on the cytostatic effect of bufalin on cervical carcinoma cells and the related mechanism

Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species‑mediated apoptosis by targeting the electron transport chain